KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,620,150 | -29.9% | 188,500 | +15.9% | 0.01% | -30.0% |
| Q2 2023 | $3,738,174 | -37.6% | 162,600 | -19.5% | 0.01% | -33.3% |
| Q1 2023 | $5,988,223 | +30.9% | 202,100 | +10.3% | 0.02% | +15.4% |
| Q4 2022 | $4,575,168 | +18.1% | 183,300 | +3.0% | 0.01% | +18.2% |
| Q3 2022 | $3,875,000 | -15.1% | 178,000 | -23.2% | 0.01% | -15.4% |
| Q2 2022 | $4,562,000 | +302.3% | 231,700 | +764.6% | 0.01% | +333.3% |
| Q1 2022 | $1,134,000 | +230.6% | 26,800 | +396.3% | 0.00% | +200.0% |
| Q4 2021 | $343,000 | – | 5,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |